Verition Fund Management LLC Fulcrum Therapeutics, Inc. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 67,043 shares of FULC stock, worth $201,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,043
Previous 37,643
78.1%
Holding current value
$201,799
Previous $134,000
135.07%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding FULC
# of Institutions
129Shares Held
51.4MCall Options Held
1.04MPut Options Held
32.6K-
Ra Capital Management, L.P. Boston, MA10.2MShares$30.8 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$15.8 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$14.4 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$14.4 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$10 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $157M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...